Výsledky vyhledávání

Akademický článek

Reduced expression of the polymeric immunoglobulin receptor in pancreatic and periampullary adenocarcinoma signifies tumour progression and poor prognosis.

Autor: Richard Fristedt, Jacob Elebro, Alexander Gaber, Liv Jonsson, Margareta Heby, Yulyana Yudina, Björn Nodin, Mathias Uhlén, Jakob Eberhard, Karin Jirström

Publikováno v: PLoS ONE, Vol 9, Iss 11, p e112728 (2014)

The polymeric immunoglobulin receptor (pIgR) is a key component of the mucosal immune system that mediates epithelial transcytosis of immunoglobulins. High pIgR expression has been reported to correlate with a less aggressive tumour phenotype and an

Externí odkaz: https://doaj.org/article/8561e07bf12c49048d260b1074831634

Zobrazit plný text záznamu

Reduced expression of the polymeric immunoglobulin receptor in pancreatic and periampullary adenocarcinoma signifies tumour progression and poor prognosis

Autor: Jakob Eberhard, Richard Fristedt, Jacob Elebro, Karin Jirström, Liv Jonsson, Margareta Heby, Björn Nodin, Mathias Uhlén, Alexander Gaber, Yulyana Yudina

Publikováno v: PLoS ONE, Vol 9, Iss 11, p e112728 (2014)
PLoS ONE; 9(11), pp 112728-112728 (2014)
PLoS ONE

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1938478d887a2d36486d1f97b9c43855
http://europepmc.org/articles/PMC4232506?pdf=render

Zobrazit plný text záznamu

High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma

Autor: Karin Jirström, Julia Bergman, Liv Jonsson, Mathias Uhlén, Björn Nodin, Marie Fridberg

Publikováno v: Diagnostic Pathology, Vol 7, Iss 1, p 82 (2012)
Diagnostic Pathology
Diagnostic Pathology; 7 (2012)

Background Malignant melanoma is the most lethal form of skin cancer with a variable clinical course even in patients with thin melanomas and localized disease. Despite increasing insights into melanoma biology, no prognostic biomarkers have yet been

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8d6fb1bedb75b25f7e83656a8e6fb81
http://www.diagnosticpathology.org/content/7/1/82

Zobrazit plný text záznamu

Modifying effect of gender on the prognostic value of clinicopathological factors and Ki67 expression in melanoma: a population-based cohort study

Autor: Liv Jonsson, Marie Fridberg, Björn Nodin, Julia Bergman, Karin Jirström

Publikováno v: Biology of Sex Differences, Vol 3, Iss 1, p 16 (2012)
Biology of Sex Differences

Background Malignant melanoma is the most deadly form of skin cancer. Female sex is known to have a protective effect on incidence, tumour characteristics, and mortality from melanoma. However, the potentially modifying effect of sex on the prognosti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48a653726e193e8e687bb1693679cd6d
http://www.bsd-journal.com/content/3/1/16

Zobrazit plný text záznamu

High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression

Autor: Mathias Uhlén, Karin Jirström, Liv Jonsson, Alexander Gaber, David Ulmert, Anders Bjartell

Publikováno v: Diagnostic Pathology, Vol 6, Iss 1, p 91 (2011)
Diagnostic Pathology; 6, no 91 (2011)
Diagnostic Pathology

Background High expression of the RNA-binding protein RBM3 has previously been found to be associated with good prognosis in breast cancer, ovarian cancer, malignant melanoma and colorectal cancer. The aim of this study was to examine the prognostic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d1a8f98ee25393974884367662b8f11
http://www.diagnosticpathology.org/content/6/1/91

Zobrazit plný text záznamu

Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: An analysis of 215 cases from the Malmö Diet and Cancer Study

Autor: Karin Jirström, Fredrik Pontén, Julia Bergman, Liv Jonsson, Jonas Manjer, Mathias Uhlén, Björn Nodin

Publikováno v: Journal of Translational Medicine, Vol 9, Iss 1, p 114 (2011)
Journal of Translational Medicine; 9, no 114 (2011)
Journal of Translational Medicine

Background We have previously reported that expression of the RNA- and DNA-binding protein RBM3 is associated with a good prognosis in breast cancer and ovarian cancer. In this study, the prognostic value of immunohistochemical RBM3 expression was as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f8b3f0390f1aa6e72a519387cafcf99
http://www.translational-medicine.com/content/9/1/114

Zobrazit plný text záznamu

High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death

Autor: Alexander Gaber, Karin Jirström, Dejan Korkocic, Björn Nodin, Mathias Uhlén, Liv Jonsson, Charlotta Hedner, Jakob Eberhard

Publikováno v: Biomarker research; 2(Jun 17), no 11 (2014)
Biomarker Research

Background High nuclear expression of the RNA-binding motif protein 3 (RBM3) has previously been found to correlate with favourable clinicopathological characteristics and a prolonged survival in several cancer forms. Here, we examined the clinicopat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e52094a92aa4e479b49c23831c73cf9

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání